Marshall Wace North America’s MiMedx Group MDXG Stock Holding History

Marshall Wace North America’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-61,211	Closed	-$556K	–	1669
2020 Q4	$556K	Buy	+61,211	New	+$441K	﹤0.01%	1070
2019 Q1	–	Sell	-144,533	Closed	-$259K	–	1763
2018 Q4	$259K	Buy	+144,533	New	+$802K	﹤0.01%	910
2018 Q2	–	Sell	-404,532	Closed	-$2.82M	–	1562
2018 Q1	$2.82M	Buy	+404,532	New	+$4.71M	0.01%	716
2013 Q4	$1.91M	Buy	+217,926	New	+$1.33M	0.04%	299

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Marshall Wace North America's MDXG Position: Q1 2021 in Review

Marshall Wace North America sold out of MiMedx Group (MDXG) in Q1 2021, closing a stake of 61,211 shares — an estimated $556K sold.

Marshall Wace North America first reported a position in MDXG in Q4 2013 and held it in 4 quarters. The position peaked at $2.82M in Q1 2018. 112 funds tracked by Wall St. Rank hold MDXG as of Q1 2021.

Marshall Wace North America reported no remaining MiMedx Group position as of Q1 2021 after selling out during the quarter.
Marshall Wace North America sold 61,211 MiMedx Group shares in Q1 2021, an estimated $556K.
Marshall Wace North America first reported a position in MiMedx Group in Q4 2013 and held it in 4 quarters.
Marshall Wace North America's MiMedx Group position peaked at $2.82M in Q1 2018.
112 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2021.

Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.